Multiple Sclerosis and Enzymes

“European physicians experienced in the use of systemic enzymes strongly believe that, contrary to the usual opinion of physicians utilizing more traditional treatments, a specific group of MS sufferers with active disease whose symptoms get worse by degrees can be helped considerably by treatment based mainly on enzyme therapy. Based on their research and experience, the physicians in the various studies feel that the progression of the patient’s paralysis can be halted and that many of the symptoms can be alleviated or even disappear. At present, science has considerable knowledge regarding the mechanisms that may lead us to learn the actual cause of multiple sclerosis. It has naturally been known for a long time that MS victims gradually suffer a functional loss of the central nervous system. This is a result of the demyelination of the nerves. The nerves are surrounded by a layer containing myelin which plays a role in the transmission of the impulse from one nerve to another. In other words, myelin is active in the transfer of messages because it insulates the nerve axons so that the messages can properly bridge the tiny gaps between the nerves. If myelin is lacking, these messages do not reach their destination. The organs affected by this disturbance in nervous conduction can no longer react and are functionally lamed.

During this search for an explanation, it became clear that most MS patients have an unusually high level of immune complexes. This has been confirmed by studies carried out independently in America, Greece, Czechoslovakia and Germany. The serum of MS patients almost always contains considerably higher concentrations of circulating immune complexes than does that of healthy individuals. This led to the suspicion that MS could be a disease dependent on or even cased by immune complexes, also known as an auto immune disease. German and other European physicians believe that the role of immune complexes in MS has been demonstrated for almost two decades now through the use of enzyme therapy. The results were very impressive.
It is unlikely that there is a physician in practice with more experience in the field of MS treatment than Dr. Neuhofer in Salzburg, Austria, who as an MS sufferer herself has been able to limit the progress of the disease with the most potent enzyme mixture. Her patients were generally recommended to follow a special diet with high proportion of raw foodstuffs and only polyunsaturated fatty acids.

Multiple sclerosis is a disease that expresses itself quite individually. There is virtually no uniform disease pattern. Every MS patient exhibits a “personal MS’ which differs somewhat or even considerably in its manifestation and course from the MS of all other sufferers. Therefore, according to Dr. Neuhofer, the whole art of treating MS with enzymes depends on taking account of this individuality, on taking the right steps at exactly the right time and with the right dosage. Dr. Neuhofer’s results are quite impressive, and should be carefully evaluated and confirmed by repeated studies. Dr. Neuhofer’s statistics reveal that of the 43 patients suffering from this intermittent progression, almost all, namely 35, demonstrated substantial improvement, with some cases going as far as the reversal of all symptoms of paralysis. The conditions of the remaining 8 patents were at least stabilized.

Dr. Neuhofer and other neurologists experienced in the medical treatment of MS with enzymes explain that there are perhaps three reasons why the enzyme therapy is not generally used for multiple sclerosis: The first is its rejection by established medical practitioners who are reluctant to deviate from conventional teaching and shirk from objectively considering and testing a new treatment scheme on a broader basis, even in the obvious absence of superior alternatives. Secondly, there is the necessity of adapting to the individual realities of each case that excludes a standard prescription of ‘a specific number of tablets three times a day’, and thus demands a great deal of flexibility, patience and understanding of the individual patient, and of the immune processes coming into play. The third reason is that the patient himself/herself is not always prepared to carry out a precise, consistent, exact therapy and to cooperate, thereby ensuring that this therapy is carried out consistently and optimally.”

“Enzymes The Fountain of Life” excerpts taken from Chapter 10, by D.A. Lopez, M.D. – R. M. Williams, M.D., Ph.D. – M. Miehlke, M. D.